← All stocks

GRI Bio, Inc.

GRI Net buying
CIK 0001824293 #5506 in the set updated 21 Sep 2026
Bought (120 mo)
$104.97K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$104.97K
+$104.97K against sales at will

By person

9 insiders · 6 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Payne Joseph E
Director
$71.80K (2)
+$71.80K
861,250
$3.51M
+2.1%
Kelly Leanne
Chief Financial Officer
$25.17K (3)
+$25.17K
6,250
$25.50K
Baker David Charles
Director
$8.00K (1)
+$8.00K
8,843
$36.08K
Hertz Walter Marc
Chief Executive Officer
385,510
$1.57M
Chaturvedi Vipin
Chief Scientific Officer
172,189
$702.53K
Agro Albert
Chief Medical Officer
172,189
$702.53K
Ammer Richard
Director
47,063
$192.02K
SALMON Pharma GmbH entity
10% owner
47,063
$192.02K
Thorell Marella
Director
9,506
$38.78K

No percentages here. This company's share count has moved by a factor of 17.0 over the window, from 525,358 to 8,933,366 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Kelly Leanne
4 Jun 2021
Chief Financial Officer
Buy
1,508
$4.08
$6.15K
Kelly Leanne
3 Jun 2021
Chief Financial Officer
Buy
1,085
$4.05
$4.39K
Kelly Leanne
2 Jun 2021
Chief Financial Officer
Buy
3,657
$4.00
$14.63K
Payne Joseph E
26 May 2021
Director
Buy
6,800
$4.50
$30.60K
Payne Joseph E
25 May 2021
Director
Buy
10,700
$3.85
$41.20K
Baker David Charles
12 Feb 2021
Chief Executive Officer
Buy
1,000
$8.00
$8.00K

What was left out

Form 4 filings counted 53
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 898,397
History held since 12 Feb 2021